EAM
Erste Asset Management’s Ginkgo Bioworks DNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.5M | Buy |
2,000,000
+350,000
| +21% | +$3.94M | 0.19% | 114 |
|
|
2025
Q1 | $9.41M | Buy |
1,650,000
+910,668
| +123% | +$5.19M | 0.12% | 161 |
|
|
2024
Q4 | $6.98M | Buy |
739,332
+239,332
| +48% | +$2.26M | 0.09% | 206 |
|
|
2024
Q3 | $4.08M | Sell |
500,000
-7,500,000
| -94% | -$61.1M | 0.05% | 262 |
|
|
2024
Q2 | $2.67M | Sell |
8,000,000
-2,800,000
| -26% | -$936K | 0.04% | 279 |
|
|
2024
Q1 | $12.5M | Hold |
10,800,000
| – | – | 0.17% | 134 |
|
|
2023
Q4 | $18.3M | Buy |
10,800,000
+2,392,236
| +28% | +$4.04M | 0.27% | 106 |
|
|
2023
Q3 | $15.2M | Hold |
8,407,764
| – | – | 0.26% | 104 |
|
|
2023
Q2 | $15.6M | Buy |
8,407,764
+2,000,000
| +31% | +$3.72M | 0.28% | 102 |
|
|
2023
Q1 | $8.52M | Buy |
6,407,764
+2,100,000
| +49% | +$2.79M | 0.16% | 151 |
|
|
2022
Q4 | $7.28M | Buy |
4,307,764
+657,764
| +18% | +$1.11M | 0.15% | 158 |
|
|
2022
Q3 | $11.4M | Buy |
3,650,000
+650,000
| +22% | +$2.03M | 0.26% | 110 |
|
|
2022
Q2 | $7.14M | Buy |
3,000,000
+1,300,000
| +76% | +$3.09M | 0.16% | 157 |
|
|
2022
Q1 | $6.85M | Buy |
+1,700,000
| New | +$6.85M | 0.13% | 186 |
|